<unk>  is a monoclonal antibody that is FDA approved for the treatment of active autoantibody-positive systemic lupus erythematosus.   Common adverse reactions include Diarrhea, nausea, infectious disease, infusion reaction, nasopharyngitis, fever.
Belimumab
Sarilumab
Golimumab
Nebacumab
Burosumab
Belatacept
Tofacitinib
Avelumab